ATE524565T1 - Transkriptionsuntreue, nachweis und verwendungen davon - Google Patents

Transkriptionsuntreue, nachweis und verwendungen davon

Info

Publication number
ATE524565T1
ATE524565T1 AT07787788T AT07787788T ATE524565T1 AT E524565 T1 ATE524565 T1 AT E524565T1 AT 07787788 T AT07787788 T AT 07787788T AT 07787788 T AT07787788 T AT 07787788T AT E524565 T1 ATE524565 T1 AT E524565T1
Authority
AT
Austria
Prior art keywords
infidelity
evidence
transcription infidelity
design
disease
Prior art date
Application number
AT07787788T
Other languages
English (en)
Inventor
Bernard Bihain
Original Assignee
Transmedi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transmedi Sa filed Critical Transmedi Sa
Application granted granted Critical
Publication of ATE524565T1 publication Critical patent/ATE524565T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Glass Compositions (AREA)
  • Pit Excavations, Shoring, Fill Or Stabilisation Of Slopes (AREA)
  • Peptides Or Proteins (AREA)
AT07787788T 2006-07-20 2007-07-20 Transkriptionsuntreue, nachweis und verwendungen davon ATE524565T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06291176A EP1887088A1 (de) 2006-07-20 2006-07-20 Transkriptionsveruntreuung, Erkennung und Verwendung
PCT/EP2007/057541 WO2008009751A2 (en) 2006-07-20 2007-07-20 Transcription infidelity, detection and uses thereof

Publications (1)

Publication Number Publication Date
ATE524565T1 true ATE524565T1 (de) 2011-09-15

Family

ID=37496681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07787788T ATE524565T1 (de) 2006-07-20 2007-07-20 Transkriptionsuntreue, nachweis und verwendungen davon

Country Status (18)

Country Link
US (1) US8288091B2 (de)
EP (3) EP1887088A1 (de)
JP (1) JP5298013B2 (de)
KR (1) KR101502179B1 (de)
AT (1) ATE524565T1 (de)
AU (1) AU2007275068B2 (de)
BR (1) BRPI0714563B8 (de)
CA (1) CA2658305C (de)
CY (2) CY1112125T1 (de)
DK (2) DK2468885T3 (de)
ES (2) ES2373428T3 (de)
HU (1) HUE028135T2 (de)
IL (1) IL196600A0 (de)
PL (2) PL2468885T3 (de)
PT (2) PT2046986E (de)
SI (2) SI2046986T1 (de)
TR (1) TR201112295Y (de)
WO (1) WO2008009751A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2071334A1 (de) * 2007-12-14 2009-06-17 Transmedi SA Zusammensetzungen und Verfahren zur Detektion von TIABS
EP2080812A1 (de) 2008-01-18 2009-07-22 Transmedi SA Zusammensetzungen und Verfahren zur Detektion von Post-Stopp-Peptiden
EP2995688A1 (de) 2014-09-12 2016-03-16 Genclis Methoden der Prognostizierung und Behandlung von triple negativem Brustkrebs
US20170168055A1 (en) * 2015-12-11 2017-06-15 Expression Pathology, Inc. SRM/MRM Assays
US11234445B2 (en) 2016-03-18 2022-02-01 Genclis Molecular origin of allergy
WO2018187216A1 (en) * 2017-04-03 2018-10-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Expression cassettes and methods for detecting transcription errors
WO2019084158A1 (en) 2017-10-26 2019-05-02 Ultima Genomics, Inc. METHODS AND SYSTEMS FOR SEQUENCE CALL
CN113795887A (zh) 2019-03-10 2021-12-14 阿尔缇玛基因组学公司 用于序列判定的方法和系统
US11926817B2 (en) 2019-08-09 2024-03-12 Nutcracker Therapeutics, Inc. Microfluidic apparatus and methods of use thereof
KR102334576B1 (ko) * 2019-08-12 2021-12-07 한국생명공학연구원 융합 단백질 및 이를 포함하는 바이오 이미징용 조성물
EP4211268A4 (de) * 2020-09-10 2024-09-18 Ultima Genomics, Inc. Verfahren und systeme für sequenz- und variantenaufruf
WO2022108309A1 (ko) * 2020-11-18 2022-05-27 한양대학교 에리카산학협력단 인산화된 비멘틴의 과도한 생성을 차단하여 암을 예방 또는 치료하는 방법
EP4162948A1 (de) 2021-10-05 2023-04-12 Genclis Transkriptionsabweichungsabgeleitete chimäre immunogene und ihre verwendungen
WO2023104904A2 (en) 2021-12-08 2023-06-15 Genclis The sars-cov-2 and variants use two independent cell receptors to replicate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4979330A (en) 1989-10-10 1990-12-25 Rorant Julius W Suction insect trap device
US6120992A (en) 1993-11-04 2000-09-19 Valigene Corporation Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification in a diseased human
AU2715601A (en) * 1999-12-03 2001-06-12 Koninklijke Nederlandse Akademie Van Wetenschappen Clearance of aberrant protein in correlation with disease
WO2002077286A1 (en) 2001-02-21 2002-10-03 Gene Check, Inc. Mutation detection using muts and reca
US20060110762A1 (en) * 2004-11-10 2006-05-25 Sanjay Kapil Porcine reproductive and respiratory syndrome virus receptor components and uses thereof

Also Published As

Publication number Publication date
EP2046986B1 (de) 2011-09-14
AU2007275068B2 (en) 2013-06-06
TR201112295Y (tr) 2018-08-27
BRPI0714563B1 (pt) 2019-07-02
BRPI0714563A2 (pt) 2015-04-14
KR101502179B1 (ko) 2015-03-12
EP1887088A1 (de) 2008-02-13
BRPI0714563B8 (pt) 2021-05-25
ES2373428T3 (es) 2012-02-03
EP2468885B1 (de) 2015-08-19
WO2008009751A2 (en) 2008-01-24
SI2046986T1 (sl) 2012-05-31
US20090317386A1 (en) 2009-12-24
AU2007275068A1 (en) 2008-01-24
EP2468885A3 (de) 2012-08-29
US8288091B2 (en) 2012-10-16
EP2468885A2 (de) 2012-06-27
CY1112125T1 (el) 2015-11-04
HUE028135T2 (en) 2016-12-28
PL2046986T3 (pl) 2012-02-29
ES2553435T3 (es) 2015-12-09
CY1116939T1 (el) 2017-04-05
CA2658305A1 (en) 2008-01-24
CA2658305C (en) 2017-07-18
JP5298013B2 (ja) 2013-09-25
KR20090052861A (ko) 2009-05-26
PT2046986E (pt) 2011-12-29
EP2046986A2 (de) 2009-04-15
DK2468885T3 (da) 2016-02-29
IL196600A0 (en) 2009-11-18
PL2468885T3 (pl) 2016-04-29
SI2468885T1 (sl) 2016-02-29
DK2046986T3 (da) 2012-01-02
HK1128937A1 (en) 2009-11-13
PT2468885E (pt) 2015-11-26
WO2008009751A3 (en) 2008-07-31
JP2009544284A (ja) 2009-12-17

Similar Documents

Publication Publication Date Title
IL196600A0 (en) Transcription infidelity, detection and uses thereof
WO2008088849A3 (en) Inflammation treatment, detection and monitoring via trem-1
WO2010054386A3 (en) Methods, compositions, and devices utilizing microrna to determine physiological conditions
WO2012142301A3 (en) Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
MX2012001716A (es) Marcadores biologicos para monitorizar la respuesta del paciente a los antagonistas vegf.
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
WO2005103281A3 (en) Platelet biomarkers for the detection of disease
WO2009018447A3 (en) Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions
DK2005162T3 (da) Screeningsmetode
WO2006073682A3 (en) Diagnostic test
EP2073843A4 (de) Verfahren zur diagnostizierung, behandlung oder verhinderung von plasmazellen-erkrankungen
ATE470151T1 (de) Diagnose, behandlung und prävention von gefässerkrankungen mittels il-1alpha- autoantikörpern
JP2010256190A5 (de)
EP2081596A4 (de) Verfahren zum nachweis von augenkrankheiten und pathologischen zuständen und behandlung dafür
EP2857522A3 (de) Verfahren zur Identifizierung, Beurteilung, Prävention und Behandlung von Lungenerkrankungen sowie Kits dafür mit geschlechtsspezifischer Krankheitsidentifizierung, Beurteilung, Prävention und Behandlung
NO20074610L (no) Fremgangsmate for a bestemme mottakeligheten til CHK1 inhibitorer
WO2008060400A3 (en) Sirtuin polymorphisms and methods of use thereof
WO2009087689A3 (en) Novel primers for identification of astrocytoma, it's grades and glioblastoma prognosis
WO2005089310A3 (en) Breath test for oral malodor
WO2006074450A3 (en) Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
EP1756571A4 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
ATE495271T1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
BR112014007947A2 (pt) método para monitoramento, diagnóstico e/ou prognóstico de distúrbios relacionados à hipoxia usando nfat5
WO2009143512A3 (en) Compositions and methods relating to detection of soluble e-cadherin in neurodegenerative disease
WO2012098542A3 (en) Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2046986

Country of ref document: EP